We currently have eleven Abbreviated New Drug Applications awaiting FDA approval. Upcoming Milestones 2013 includes : 1) US Market launch of fourth Product Econazole in 3Q 2013 2) Minimum 2 FDA approvals before year end 2013 3) Another 3 ANDA filings in 2H 2013 4) Achieve Profitability in 2013 Issued Shares: 43.21 Million Insider and Institutional Ownership: 72% Top 6 Shareholder of IG : Life Sciences opp Fund 16.4 M Amzak Capital 3.8 M Gerardi Francis 3.3 M Morris Stephen 2.8 M Hager Edward 2.1 M Visium assets 1.2 M